Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SUHAX vs. QAAGZX: which is better?

Bottom line

SUHAX vs QAAGZX: the short answer

SUHAX (DWS Health and Wellness Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.

But QAAGZX is far broader, holding 277 positions to 65 for SUHAX, so beyond the top names it adds exposure SUHAX doesn't have.

QAAGZX is cheaper at 0.86% vs 1.34% — a difference of $48 a year per $10,000 invested.

SUHAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

SUHAX vs QAAGZX side by side

SUHAXQAAGZX
TypeMutual fundETF
Fund familyDWS (Xtrackers)T. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.34%0.86%
Annual cost per $10k$134$86
10-yr cost on $10k (prospectus)$2,095$1,061
Max front load5.75%None
12b-1 fee0.24%0%
1-yr return—+18.1%
5-yr return (annualized)—+4.1%
10-yr return (annualized)—+9.0%
Best quarter+17.1%+23.4%
Worst quarter−12.1%−15.8%
Net assets (fund)$231.8M$751.7M
Number of holdings65277
Portfolio turnover2%65%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSUHAXQAAGZXDifference
2025+12.3%+18.1%−5.8%
2024+3.3%+1.7%+1.7%
2023+5.1%+3.0%+2.2%
2022−7.4%−12.5%+5.0%
2021+15.0%+13.1%+1.9%
2020+15.1%+29.6%−14.5%
2019+21.9%+29.0%−7.0%
2018+3.3%+1.1%+2.2%
2017+19.0%+27.6%−8.6%
2016−10.5%−10.5%+0.0%

Source: Fund prospectus bar charts

Holdings overlap

15 of SUHAX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingSUHAXQAAGZX
Eli Lilly & Co13.85%14.06%
Johnson & Johnson6.19%6.64%
UnitedHealth Group Inc5.73%5.88%
AbbVie Inc4.90%5.12%
Merck & Co Inc4.85%4.00%
Thermo Fisher Scientific Inc3.46%2.53%
Amgen Inc2.88%1.80%
Gilead Sciences Inc2.78%2.79%
Intuitive Surgical Inc2.69%1.89%
Stryker Corp2.61%1.78%
Vertex Pharmaceuticals Inc2.45%2.26%
Abbott Laboratories2.39%1.91%
Danaher Corp2.13%1.44%
Bristol-Myers Squibb Co1.50%2.12%
Cardinal Health Inc1.34%1.04%

Source: SEC Form N-PORT

SUHAX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between SUHAX and QAAGZX?
SUHAX (DWS Health and Wellness Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. But QAAGZX is far broader, holding 277 positions to 65 for SUHAX, so beyond the top names it adds exposure SUHAX doesn't have.
Which is cheaper, SUHAX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both SUHAX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.